Data Dictionary: Czech Republic's National Cancer Registry - Revision history

Lucas: Update categories.

2025-12-02T13:26:02Z

Update categories.

← Older revision		Revision as of 13:26, 2 December 2025
Line 1:		Line 1:
	{{forresearchers~~}} {{~~czechrepubliccountry}}		<span style="display:none">forresearchers</span> <span style="display:none">czechrepubliccountry</span>
	Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page		Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page

Francine at 12:11, 2 December 2025

2025-12-02T12:11:58Z

← Older revision		Revision as of 12:11, 2 December 2025
Line 1:		Line 1:
	{{forresearchers}}		{{forresearchers}} {{czechrepubliccountry}}
	Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page		Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page

Victor at 14:44, 26 August 2024

2024-08-26T14:44:27Z

← Older revision		Revision as of 14:44, 26 August 2024
Line 39:		Line 39:
	\| dat_dg \|\| Date of diagnosis		\| dat_dg \|\| Date of diagnosis
	\|-		\|-
	\| lateralita \|\| ~~Tumor~~ laterality		\| lateralita \|\| Tumour laterality
	\|-		\|-
	\| dg_stan \|\| These examinations led to the diagnosis		\| dg_stan \|\| These examinations led to the diagnosis
Line 49:		Line 49:
	\| topo \|\| Topography code according to ICD-O-3 classification		\| topo \|\| Topography code according to ICD-O-3 classification
	\|-		\|-
	\| morfo_slovne \|\| ~~Tumor~~ morphology in words		\| morfo_slovne \|\| Tumour morphology in words
	\|-		\|-
	\| morfo_metoda \|\| Method for determining ~~tumor~~ morphology		\| morfo_metoda \|\| Method for determining tumour morphology
	\|-		\|-
	\| morfo \|\| ~~Tumor~~ morphology according to ICD-O-3 classification		\| morfo \|\| Tumour morphology according to ICD-O-3 classification
	\|-		\|-
	\| grade \|\| ~~Tumor~~ grading		\| grade \|\| Tumour grading
	\|-		\|-
	\| t \|\| T classification according to TNM 8		\| t \|\| T classification according to TNM 8
Line 81:		Line 81:
	\| trofoblast \|\| Risk category for trophoblast		\| trofoblast \|\| Risk category for trophoblast
	\|-		\|-
	\| serove_markery \|\| Serum ~~tumor~~ markers in testicular ~~tumors~~		\| serove_markery \|\| Serum tumour markers in testicular tumours
	\|-		\|-
	\| p16 \|\| p16 positivity (for oropharynx only)		\| p16 \|\| p16 positivity (for oropharynx only)
Line 95:		Line 95:
	\| specificke_stadium \|\| Specific stage for childhood types of cancer		\| specificke_stadium \|\| Specific stage for childhood types of cancer
	\|-		\|-
	\| lecba_novotvaru \|\| Was anti-~~tumor~~ treatment applied?		\| lecba_novotvaru \|\| Was anti-tumour treatment applied?
	\|-		\|-
	\| odpoved \|\| Response to anticancer treatment		\| odpoved \|\| Response to anticancer treatment
Line 197:		Line 197:

	{\| class="wikitable"		{\| class="wikitable"
	! Data interface for transmitting results from pathology/cytology departments - Pathological Examination of ~~Tumors~~		! Data interface for transmitting results from pathology/cytology departments - Pathological Examination of Tumours
	\|-		\|-
	! Value !! Field description		! Value !! Field description
Line 215:		Line 215:
	\| topo \|\| Topography		\| topo \|\| Topography
	\|-		\|-
	\| pt \|\| pT (extent of primary ~~tumor~~)		\| pt \|\| pT (extent of primary tumour)
	\|-		\|-
	\| pnrn \|\| Largest ~~tumor~~ dimension (in mm)		\| pnrn \|\| Largest tumour dimension (in mm)
	\|-		\|-
	\| pn \|\| pN (absence or presence and extent of metastases in regional lymph nodes)		\| pn \|\| pN (absence or presence and extent of metastases in regional lymph nodes)
Line 227:		Line 227:
	\| pm \|\| pM (absence or presence of distant metastases)		\| pm \|\| pM (absence or presence of distant metastases)
	\|-		\|-
	\| rn \|\| Residual ~~tumor~~		\| rn \|\| Residual tumour
	\|-		\|-
	\| sdyspl \|\| Precancer - degree of dysplasia		\| sdyspl \|\| Precancer - degree of dysplasia
Line 233:		Line 233:
	\| info_text \|\| Additional information		\| info_text \|\| Additional information
	\|-		\|-
	\| ptmm \|\| ~~Tumor~~ size (in mm)		\| ptmm \|\| Tumour size (in mm)
	\|-		\|-
	\| gleason1 \|\| Gleason differentiation 1 (for prostate cancer)		\| gleason1 \|\| Gleason differentiation 1 (for prostate cancer)

Francine at 13:04, 27 May 2024

2024-05-27T13:04:01Z

← Older revision		Revision as of 13:04, 27 May 2024
Line 1:		Line 1:
			{{forresearchers}}
	Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page		Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page

Francine at 16:11, 6 May 2024

2024-05-06T16:11:06Z

← Older revision		Revision as of 16:11, 6 May 2024
Line 1:		Line 1:
	Go back to [[Czech Republic]] page		Go back to [[Database: ÚZIS National Cancer Registry (Czech Republic)]] page

	Source: [https://www.uzis.cz/index.php?pg=registry-sber-dat--narodni-zdravotni-registry--narodni-onkologicky-registr#datove-rozhrani]		Source: [https://www.uzis.cz/index.php?pg=registry-sber-dat--narodni-zdravotni-registry--narodni-onkologicky-registr#datove-rozhrani Click here to learn more]

	{\| class="wikitable"		{\| class="wikitable"

Larysse at 21:40, 25 November 2023

2023-11-25T21:40:07Z

Show changes

Larysse at 21:37, 25 November 2023

2023-11-25T21:37:24Z

@@ Line 196: / Line 196: @@
 {| class="wikitable"
-! Data interface for transmitting results from pathology/cytology departments - pathological examination of tumors
+! Data interface for transmitting results from pathology/cytology departments - Pathological Examination of Tumors
 |-
 ! Value !! Field description
@@ Line 238: / Line 238: @@
 | gleason2 || Gleason differentiation 2 (for prostate cancer)
 |}

Larysse at 21:36, 25 November 2023

2023-11-25T21:36:20Z

@@ Line 193: / Line 193: @@
 |-
 | auzku || communication for reporting performance or ZÚM for this clinical event
 |}

Larysse at 21:31, 25 November 2023

2023-11-25T21:31:26Z

@@ Line 1: / Line 1: @@
 Go back to [[Czech Republic]] page
 {| class="wikitable"
@@ Line 98: / Line 99: @@
 |}
 '''1. Data related to the patient's health status in relation to his illness'''

Larysse at 21:11, 25 November 2023

2023-11-25T21:11:46Z

← Older revision		Revision as of 21:11, 25 November 2023
Line 1:		Line 1:
	Go back to [[Czech Republic]] page		Go back to [[Czech Republic]] page


			{\| class="wikitable"
			! Data interface for the transmission of clinical reports
			\|-
			! Value !! Field description
			\|-
			\| idzz \|\| Identification of a record from a medical facility.
			\|-
			\| hzz \|\| Identifier of the reporting workplace
			\|-
			\| hodd \|\| Department of the reporting workplace
			\|-
			\| htyp \|\| The type of care provided to the patient
			\|-
			\| hdatum \|\| Date of reporting
			\|-
			\| rodcis \|\| Patient birth number
			\|-
			\| jmeno \|\| Patient name
			\|-
			\| prijmeni \|\| Patient's last name
			\|-
			\| pohlavi \|\| Gender of the patient
			\|-
			\| dat_nar \|\| Patient's date of birth
			\|-
			\| obec \|\| Code of the municipality of permanent residence
			\|-
			\| cizinec \|\| The patient is a foreigner
			\|-
			\| bezdomovec \|\| The patient is homeless
			\|-
			\| zeme \|\| Patient's country of origin
			\|-
			\| dat_dg \|\| Date of diagnosis
			\|-
			\| lateralita \|\| Tumor laterality
			\|-
			\| dg_stan \|\| These examinations led to the diagnosis
			\|-
			\| dg_nov_slovne \|\| Diagnosis verbally
			\|-
			\| dg_nov \|\| Diagnosis code according to ICD-10 classification
			\|-
			\| topo \|\| Topography code according to ICD-O-3 classification
			\|-
			\| morfo_slovne \|\| Tumor morphology in words
			\|-
			\| morfo_metoda \|\| Method for determining tumor morphology
			\|-
			\| morfo \|\| Tumor morphology according to ICD-O-3 classification
			\|-
			\| grade \|\| Tumor grading
			\|-
			\| t \|\| T classification according to TNM 8
			\|-
			\| n \|\| N classification according to TNM 8
			\|-
			\| m \|\| M classification according to TNM 8
			\|-
			\| ptnmy \|\| Symptom according to TNM classification
			\|-
			\| pt \|\| pT classification according to TNM 8
			\|-
			\| pn \|\| pN classification according to TNM 8
			\|-
			\| pvu \|\| Number of examined lymph nodes
			\|-
			\| ppu \|\| Number of positive lymph nodes
			\|-
			\| psu \|\| Sentinel lymph node examination result
			\|-
			\| pm \|\| pM classification according to TNM 8
			\|-
			\| metastaze \|\| Localization of metastases
			\|-
			\| trofoblast \|\| Risk category for trophoblast
			\|-
			\| serove_markery \|\| Serum tumor markers in testicular tumors
			\|-
			\| p16 \|\| p16 positivity (for oropharynx only)
			\|-
			\| stadium \|\| TNM clinical stage 8
			\|-
			\| rozsah \|\| Disease progression
			\|-
			\| lekar \|\| Name of reporting/responsible physician
			\|-
			\| pozn \|\| Note on neoplasm
			\|-
			\| specificke_stadium \|\| Specific stage for childhood types of cancer
			\|-
			\| lecba_novotvaru \|\| Was anti-tumor treatment applied?
			\|-
			\| odpoved \|\| Response to anticancer treatment
			\|}


	'''1. Data related to the patient's health status in relation to his illness'''		'''1. Data related to the patient's health status in relation to his illness'''